Production of good manufacturing practice-grade human umbilical cord blood-derived mesenchymal stem cells for therapeutic use

Methods in Molecular Biology

Volumn 1283, Issue , 2015, Pages 73-85

  van Pham, Phuc ^a   Phan, Ngoc Kim ^a  

^a NONE

Author keywords

Good manufacturing practice; Mesenchymal stem cells; Therapeutic use; UCB MSCs; Umbilical cord blood

Indexed keywords

GROWTH FACTOR;

ADIPOCYTE; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL LINEAGE; CELLS BY BODY ANATOMY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; MUSCLE CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD; BIOLOGICAL THERAPY; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; STANDARDS;

CELL CULTURE TECHNIQUES; CELL SEPARATION; CELL- AND TISSUE-BASED THERAPY; FETAL BLOOD; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS;

EID: 84923033490     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2014_125     Document Type: Article

References (39)

1. Friedenstein AJ, Piatetzky S II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16 (3):381–390
2. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2(2):83–92
3. Prockop DJ, Sekiya I, Colter DC (2001) Isolation and characterization of rapidly self-renewingstem cells from culturesofhuman marrow stromal cells. Cytotherapy 3(5):393–396. doi:10.1080/146532401753277229
4. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D (2002) Isolation and characterization of bone marrow mul-tipotential mesenchymal progenitor cells. Arthritis Rheum 46(12):3349–3360. doi:10.1002/art.10696
5. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C (2008) Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45(2):115–120. doi:10.1016/j.ymeth.2008.03.006
6. Boquest AC, Shahdadfar A, Brinchmann JE, Collas P (2006) Isolation of stromal stem cells from human adipose tissue. Methods Mol Biol 325:35–46. doi:10.1385/1-59745-005-7:35
7. Ulrich D, Muralitharan R, Gargett CE (2013) Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. Expert Opin Biol Ther 13 (10):1387–1400. doi:10.1517/14712598.2013.826187
8. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103(5):1669–1675. doi:10.1182/blood-2003-05-1670
9. Phuc PV, Ngoc VB, Lam DH, Tam NT, Viet PQ, Ngoc PK (2012) Isolation of three important types of stem cells from the same samples of banked umbilical cord blood. Cell Tissue Bank 13(2):341–351. doi:10.1007/s10561-011-9262-4
10. Gong W, Han Z, Zhao H, Wang Y, Wang J, Zhong J, Wang B, Wang S, Wang Y, Sun L, Han Z (2012) Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Cell Transplant 21(1):207–216. doi:10.3727/096368911x586756
11. Kosmacheva SM, Seviaryn IN, Goncharova NV, Petyovka NV, Potapnev MP (2011) Hepa-togenic potential of human bone marrow and umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med 151(1):142–149
12. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H (2005) In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 330(4):1153–1161. doi:10.1016/j.bbrc.2005.03.086
13. Jin HJ, Nam HY, Bae YK, Kim SY, Im IR, Oh W, Yang YS, Choi SJ, Kim SW (2010) GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells. Cell Mol Life Sci 67(11):1845–1858. doi:10.1007/s00018-010-0292-z
14. Yang S, Xue DD, Wu B, Sun HM, Li XS, Dong F, Li WS, Ji FQ, Zhou DS (2013) Pleiotrophin is involved in the amniotic epithelial cell-induced differentiation of human umbilical cord blood-derived mesenchymal stem cells into dopaminergic neuron-like cells. Neurosci Lett 539:86–91. doi:10.1016/j.neulet.2013.01.046
15. Jeong JA, Gang EJ, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H, Kim H (2004) Rapid neural differentiation of human cord blood-derived mesenchymal stem cells. Neuroreport 15(11):1731–1734
16. Fang CH, Jin J, Joe JH, Song YS, So BI, Lim SM, Cheon GJ, Woo SK, Ra JC, Lee YY, Kim KS (2012) In vivo differentiation of human amniotic epithelial cells into cardiomyocyte-like cells and cell transplantation effect on myo-cardial infarction in rats: comparison with cord blood and adipose tissue-derived mesenchymal stem cells. Cell Transplant 21(8):1687–1696. doi:10.3727/096368912x653039
17. Roura S, Farre J, Hove-Madsen L, Prat-Vidal C, Soler-Botija C, Galvez-Monton C, Vilalta M, Bayes-Genis A (2010) Exposure to cardio-myogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesen-chymal stem cells. Basic Res Cardiol 105 (3):419–430. doi:10.1007/s00395-009-0081-8
18. Nishiyama N, Miyoshi S, Hida N, Uyama T, Okamoto K, Ikegami Y, Miyado K, Segawa K, Terai M, Sakamoto M, Ogawa S, Umezawa A (2007) The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 25(8):2017–2024. doi:10.1634/stemcells.2006-0662
19. Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, Xu J (2009) The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126(2):220–232. doi:10.1111/j.1365-2567.2008.02891.x
20. Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, Sung KW, Kim CW, Koo HH (2009) Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259 (2):150–156. doi:10.1016/j.cellimm.2009.06.010
21. Shi D, Wang D, Li X, Zhang H, Che N, Lu Z, Sun L (2012) Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus. Clin Rheumatol 31 (5):841–846. doi:10.1007/s10067-012-1943-2
22. Lee H, Bae JS, Jin HK (2010) Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of Niemann-Pick type C mouse by modulation of neuroinflammatory condition. J Vet Med Sci 72(6):709–717
23. Gregoire-Gauthier J, Selleri S, Fontaine F, Dieng MM, Patey N, Despars G, Beausejour CM, Haddad E (2012) Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model. Stem Cells Dev 21(10):1616–1626. doi:10.1089/scd.2011.0413
24. Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, Huan Y, Ge RC, Chen XW, Wang ZJ, Kim BJ, Hu X (2013) Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med 11:196. doi:10.1186/1479-5876-11-196
25. Jin JL, Liu Z, Lu ZJ, Guan DN, Wang C, Chen ZB, Zhang J, Zhang WY, Wu JY, Xu Y (2013) Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res 10 (1):11–20
26. Li XY, Zheng ZH, Li XY, Guo J, Zhang Y, Li H, Wang YW, Ren J, Wu ZB (2013) Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies. Curr Pharm Des 19(27):4893–4899
27. Han H, Chang SK, Chang JJ, Hwang SH, Han SH, Chun BH (2011) Intrathecal injection of human umbilical cord blood-derived mesen-chymal stem cells for the treatment of basilar artery dissection: a case report. J Med Case Reports 5:562. doi:10.1186/1752-1947-5-562
28. Yang SS, Kim NR, Park KB, Do YS, Roh K, Kang KS, Kim DI (2013) A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease. Int J Stem Cells 6(1):37–44
29. Kocaoemer A, Kern S, Kluter H, Bieback K (2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25(5):1270–1278. doi:10.1634/stemcells.2006-0627
30. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, Kluter H (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27 (9):2331–2341. doi:10.1002/stem.139
31. Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE (2013) Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One 8(7):e68984. doi:10.1371/journal.pone.0068984
32. Rauch C, Feifel E, Amann EM, Spotl HP, Schennach H, Pfaller W, Gstraunthaler G (2011) Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. ALTEX 28 (4):305–316
33. Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, Schettert IT, Krie-ger JE (2009) Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 49 (12):2680–2685. doi:10.1111/j.1537-2995.2009.02346.x
34. Ding Y, Yang H, Feng JB, Qiu Y, Li DS, Zeng Y (2013) Human umbilical cord-derived MSC culture: the replacement of animal sera with human cord blood plasma. In Vitro Cell Dev Biol Anim 49(10):771–777. doi:10.1007/s11626-013-9663-8
35. Shetty P, Bharucha K, Tanavde V (2007) Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchy-mal stem cells. Cell Biol Int 31(3):293–298. doi:10.1016/j.cellbi.2006.11.010
36. Ma HY, Yao L, Yu YQ, Li L, Ma L, Wei WJ, Lu XM, Du LL, Jin YN (2012) An effective and safe supplement forstemcells expansionexvivo: cord blood serum. Cell Transplant 21(5):857–869. doi:10.3727/096368911x612486
37. Murphy MB, Blashki D, Buchanan RM, Yazdi IK, Ferrari M, Simmons PJ, Tasciotti E (2012) Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials 33 (21):5308–5316. doi:10.1016/j.biomaterials.2012.04.007
38. Escobedo-Lucea C, Bellver C, Gandia C, Sanz-Garcia A, Esteban FJ, Mirabet V, Forte G, Moreno I, Lezameta M, Ayuso-Sacido A, Garcia-Verdugo JM (2013) A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses. PLoS One 8 (7):e67870. doi:10.1371/journal.pone.0067870
39. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesen-chymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317. doi:10.1080/14653240600855905